Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID‐19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical practice.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Koba, Hayato, Yoneda, Taro, Kaneda, Tomoya, Ueda, Tsukasa, Kimura, Hideharu, Kasahara, Kazuo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537071/
https://ncbi.nlm.nih.gov/pubmed/33042544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados